French drugmaker Sanofi (SNYNF) and GlaxoSmithKline (GSK) will be granted up to $2.1 billion by the U.
Sanofi (SNYNF) and GSK (GSK) have now confirmed an agreement with the UK government for the supply of up to 60 million doses …
GlaxoSmithKline (GSK) will buy a 10% stake in Germany’s CureVac as part of a strategic collaboration to develop and commercialize up to five …
The European Union is reportedly in talks to make advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna (MRNA), Sanofi (SNY) and …
French drugmaker Sanofi (SNY) said that the U.S.
French multinational pharma Sanofi (SNYNF) can produce as many as 600 million doses of its coronavirus vaccine next year if everything goes to …
British drugmaker GlaxoSmithKline (GSK) and Vir Biotechnology Inc (VIR) on Monday announced a partnership to develop potential antibody treatments for COVID-19, the disease …
Agenus Inc (NASDAQ:AGEN), an immunology company discovering and developing innovative treatments for cancers and other diseases, announced that GlaxoSmithKline plc (ADR) (NYSE:GSK) received a …
In a research note published today, Argus analyst John Eade upgraded GlaxoSmithKline (NYSE:GSK) to a Buy rating with a $55 price target, on …
Ligand Pharma (NASDAQ:LGND) partner GlaxoSmithKline (NYSE:GSK) announced it received FDA approval for the sNDA of Promacta for treatment of cytopenia in patients with …
